{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:22:26Z","timestamp":1758079346734,"version":"3.44.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,16]]},"DOI":"10.7759\/cureus.92448","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:05:01Z","timestamp":1758031501000},"source":"Crossref","is-referenced-by-count":0,"title":["Pseudoprogression of Non-Small Cell Lung Cancer Following Neoadjuvant Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Kareem","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Benaissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Shackcloth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3708","article-title":"Overall survival and long-term safety of nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer","volume":"33","author":"Gettinger SN","year":"2015","unstructured":"Gettinger SN, Horn L, Gandhi L, et al.. Overall survival and long-term safety of nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer. J Clin Oncol. 2015, 33:2004-12. 10.1200\/JCO.2014.58.3708","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde PM","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, et al.. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022, 386:1973-85. 10.1056\/NEJMoa2202170","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13665","article-title":"Current status and future perspectives on immunotherapy in neoadjuvant therapy of resectable non-small cell lung cancer","volume":"18","author":"Liu X","year":"2022","unstructured":"Liu X, Xing H, Liu H, Chen J. Current status and future perspectives on immunotherapy in neoadjuvant therapy of resectable non-small cell lung cancer. Asia Pac J Clin Oncol. 2022, 18:335-43. 10.1111\/ajco.13665","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2025.04.002","article-title":"Operative challenges after induction immunotherapy for lung cancer","volume":"35","author":"Hawkins A","year":"2025","unstructured":"Hawkins A, Martin LW. Operative challenges after induction immunotherapy for lung cancer. Thorac Surg Clin. 2025, 35:285-98. 10.1016\/j.thorsurg.2025.04.002","journal-title":"Thorac Surg Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020200443","article-title":"Incidence of pseudoprogression during immune checkpoint inhibitor therapy for solid tumors: a systematic review and meta-analysis","volume":"297","author":"Park HJ","year":"2020","unstructured":"Park HJ, Kim KW, Pyo J, Suh CH, Yoon S, Hatabu H, Nishino M. Incidence of pseudoprogression during immune checkpoint inhibitor therapy for solid tumors: a systematic review and meta-analysis. Radiology. 2020, 297:87-96. 10.1148\/radiol.2020200443","journal-title":"Radiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"378","author":"Forde PM","year":"2018","unstructured":"Forde PM, Chaft JE, Smith KN, et al.. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med. 2018, 378:1976-86. 10.1056\/NEJMoa1716078","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.633534","article-title":"Case report: Transformation from cold to hot tumor in a case of NSCLC neoadjuvant immunochemotherapy pseudoprogression","volume":"12","author":"Jia W","year":"2021","unstructured":"Jia W, Zhu H, Gao Q, et al.. Case report: Transformation from cold to hot tumor in a case of NSCLC neoadjuvant immunochemotherapy pseudoprogression. Front Immunol. 2021, 12:633534. 10.3389\/fimmu.2021.633534","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2019.0144","article-title":"The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy","volume":"16","author":"Jia W","year":"2019","unstructured":"Jia W, Gao Q, Han A, Zhu H, Yu J. The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy. Cancer Biol Med. 2019, 16:655-70. 10.20892\/j.issn.2095-3941.2019.0144","journal-title":"Cancer Biol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30453-8","article-title":"Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial","volume":"21","author":"Provencio M","year":"2020","unstructured":"Provencio M, Nadal E, Insa A, et al.. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020, 21:1413-22. 10.1016\/S1470-2045(20)30453-8","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397732-pseudoprogression-of-non-small-cell-lung-cancer-following-neoadjuvant-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:05:02Z","timestamp":1758031502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397732-pseudoprogression-of-non-small-cell-lung-cancer-following-neoadjuvant-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.92448","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}